More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$22.31B
EPS
8.18
P/E ratio
26.2
Price to sales
3.46
Dividend yield
1.206%
Beta
0.924512
Previous close
$228.49
Today's open
$227.02
Day's range
$225.01 - $230.13
52 week range
$195.14 - $269.44
CEO
Daniel A. Carestio
Employees
17937
Headquarters
Dublin 2,
Exchange
New York Stock Exchange
Shares outstanding
97500110
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
2 Healthcare Technology Stocks for a Digital Health Boom
GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
Zacks Investment Research • 10 hours ago

STERIS Announces Dividend of $0.69 per share
DUBLIN, IRELAND, Oct. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.69 per share. The dividend is payable on December 17, 2026, to shareholders of record at the close of business on November 17, 2026.
GlobeNewsWire • Oct 28, 2026

STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
DUBLIN, IRELAND, Oct. 20, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 a.m. ET on November 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
GlobeNewsWire • Oct 20, 2026

Reasons to Add STE Stock to Your Portfolio Right Now
STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
Zacks Investment Research • Oct 16, 2026

Steris to Acquire Xodus Medical for $2.1 Billion
The Dublin, Ireland provider of products and services to hospitals and pharmaceutical manufacturers said it expects the deal to expand its portfolio.
WSJ • Oct 12, 2026

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention. The acquisition represents a significant milestone in Xodus Medical's more than 30-year history, bringing together two organizations with a shared commitment to advancing patient safety, supporting healthcare professionals, and delivering innovative solutions to the surgical environment.
PRNewsWire • Oct 12, 2026

Top 3 Health Care Stocks That May Rocket Higher In September
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Benzinga • Sep 21, 2026

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha • Sep 15, 2026

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Sep 4, 2026

STERIS to Present at the Morgan Stanley Healthcare Conference
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.
GlobeNewsWire • Sep 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell STERIS plc (Ireland) commission-free¹. Build wealth for the long term using automated trading and transfers.